Dr. Monica Embers & Ravel Co-Founder Discuss Patient Pain Points on Love, Hope, Lyme Podcast
June 14, 2025

Ravel Advisory Team member Dr. Monica Embers and Ravel Co-Founder Kevin Williams had the opportunity and honor to speak with Fred Diamond on his Love, Hope, Lyme podcast recently. On his show, Fred interviews doctors, medical practitioners, charity directors, and community leaders who help him understand what living with Lyme is all about. On the podcast, he has them share their insights into how people can support those they love. If you’re a chronic Lyme survivor, the podcast will help you understand how you can let your family and friends support you how you need to be supported.
Here is the description of our conversation with him, please take a listen!
For decades, Lyme disease survivors have faced an uphill battle—dismissed by doctors, forced to wait years for appointments, and left without clear paths to healing.
In this powerful episode of the Love, Hope, Lyme Podcast, Fred Diamond speaks with Dr. Monica Embers, a leading Lyme disease researcher at Tulane University and contributor to The Quiet Epidemic, and Kevin Williams, co-founder of Ravel Health and a chronic Lyme patient of 18 years.
Dr. Embers shares the hard truth: “There is no central place for patients to turn.” She explains why outdated diagnostic tools, lack of federal investment in treatment research, and misinformation have left millions without answers—and how new tests and targeted therapies are finally changing the game.
Kevin Williams opens up about the deeply personal reasons he and co-founder, Jaime Intile, created Ravel Health: to spare others the years of pain and medical gaslighting they endured. Ravel now offers accessible, virtual, Lyme-literate care across 46 states with no waitlists and personalized treatment plans.
🎧 If you or someone you love is navigating Lyme or a related chronic illness, this episode will inform, validate, and give hope.
📌 Learn how Ravel is partnering with science leaders like Dr. Embers to change the future of Lyme care.
